Trials / Conditions / Stage III Cutaneous Melanoma
Stage III Cutaneous Melanoma
3 registered clinical trials studyying Stage III Cutaneous Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies NCT03590054 | Rahul Aggarwal | Phase 1 |
| Completed | Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma NCT03396952 | University of California, San Francisco | Phase 2 |
| Terminated | Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV NCT02587650 | University of California, San Francisco | Phase 2 |